Empty Capsules Market, By Product (Gelatin Capsulesand Non-gelatin Capsules), By Functionality (Immediate-release Capsules, Delayed-release Capsules, Sustained-release Capsules), By Material (Pig Meat Gelatin Capsules, Bovine Gelatin Capsules, Plant-based Capsules, Starch-based Capsules, Pullulan Capsules, Others), By End User (Pharmaceutical Companies, Cosmetic & Nutraceutical Companies, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2024

Code : CMI1328

Pages :174

Formats :

Excel and PDF

Industry : Pharmaceutical

Empty Capsules Market Size and Trends

Global empty capsules market is estimated to be valued at USD 3.21 Bn in 2024 and is expected to reach USD 4.91 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031.

Empty Capsules Market Key Factors

To learn more about this report, request sample copy

Global empty capsules market growth is driven by growing pharmaceutical industry and rising drug discovery activities. Factors such as rising geriatric population, increasing prevalence of chronic and lifestyle-related diseases, and growth in generics market have resulted in higher consumption of empty capsules. Development of sophisticated flavors and innovations in capsule delivery technology can offer new opportunities for empty capsules manufacturers over the forecast period.

Rising Demand from Pharmaceutical Industry

Global empty capsules market growth is driven by rising demand for capsules from the pharmaceutical industry. Growing pharmaceutical industry boosts the need for empty capsules. Empty capsules find widespread application in the pharmaceutical sector for manufacturing various medicines such as antibiotics, anti-fungal, anti-depressants, anti-hypertensives and many other drug formulas. Growing geriatric population worldwide who are more prone to chronic diseases and ailments can also boost demand for various medicines, and this boosts the need for empty capsules from pharmaceutical companies. Furthermore, increasing healthcare expenditure of people and governments across nations contributes to growth of the pharmaceutical industry. Many new drug molecules and formulations are being developed by companies, and this boosts demand for empty capsules as these are extensively used in the pharmaceutical manufacturing process. Capsule-based drug delivery offers various advantages such as targeted drug release, protection of active pharmaceutical ingredients (APIs) from environmental degradation, and enhanced bioavailability. Growing acceptability of capsule dosage forms by patients and physicians alike as compared to other forms can drive the empty capsules market growth.

/p>

The preference for capsule dosage forms

The preference for capsule dosage forms among consumers and healthcare professionals is a major factor responsible for driving growth in the global empty capsules market. Capsules offer several advantages over other dosage forms like tablets. They are easy to swallow and digest for people of all age groups including children and geriatric patients who may have difficulty swallowing tablets. The empty shell structure of capsules allows for miniaturization and ensures targeted release of active pharmaceutical ingredients in the gastrointestinal tract. This enhances bioavailability and effectiveness of the drug. Capsules are also considered more elegant and appealing alternatives to tablets by many patients. Pharmaceutical manufacturers are increasingly opting for capsule dosage forms due to their flexibility in formulations. A wide range of formulations like powders, pellets, granules and liquids can be filled into capsules with tailored drug release profiles. Nutraceutical companies have also expanded capsule offerings of supplements, vitamins and herbal/ayurvedic medicines to meet consumer demand. Rapid growth of nutraceuticals and innovations in capsule drug delivery technologies are broadening opportunities for empty capsules.